VIBURNUM OPULUS: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

Viburnum opulus is a flowering shrub. Many parts of the plant have been used as medicine.

Viburnum opulus is native to Europe and parts of Africa, Asia, and North America. In North America, the bark of the plant has traditionally been used to relieve cramps and is called cramp bark.

Viburnum opulus is used for muscle cramps, diabetes, high blood pressure, kidney stones, and other conditions, but there is no good scientific evidence to support these uses.

Uses & Effectiveness

We currently have no information for VIBURNUM OPULUS overview.

Side Effects

When taken by mouth: There isn't enough reliable information to know if Viburnum opulus is safe to use or what the side effects might be.

Special Precautions and Warnings

When taken by mouth: There isn't enough reliable information to know if Viburnum opulus is safe to use or what the side effects might be.

Pregnancy and breast-feeding: There isn't enough reliable information to know if Viburnum opulus is safe to use when pregnant or breast-feeding. Stay on the safe side and avoid use.

Interactions

We currently have no information for VIBURNUM OPULUS overview.

Dosing

There isn't enough reliable information to know what an appropriate dose of Viburnum opulus might be. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult a healthcare professional before using.

View References

REFERENCES:

Andermann G, Dietz M. The influence of the route of administration on the bioavailability of an endogenous macromolecule: chondroitin sulphate (CSA). Eur J Drug Metab Pharmacokinet 1982;7:11-6. View abstract.

Bagasra O, Whittle P, Heins B, Pomerantz RJ. Anti-human immunodeficiency virus type 1 activity of sulfated monosaccharides: comparison with sulfated polysaccharides and other polyions. J Infect Dis 1991;164:1082-90. View abstract.

Baici A, Horler D, Moser B, et al. Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulfate. Rheumatol Int 1992;12:81-8.. View abstract.

Barnhill JG, Fye CL, Williams DW, Reda DJ, Harris CL, Clegg DO. Chondroitin product selection for the glucosamine/chondroitin arthritis intervention trial. J Am Pharm Assoc (2003) 2006;46(1):14-24. View abstract.

Belalcázar-Rey S, Sánchez Huerta V, Ochoa-Tabares JC, et al. Efficacy and safety of sodium hyaluronate/chondroitin sulfate preservative-free ophthalmic solution in the treatment of dry eye: A clinical trial. Curr Eye Res. 2020:1-11. View abstract.

Bhimani J, O'Connell K, Kuk D, Du M, Navarro SL, Kantor ED. Glucosamine and Chondroitin Use and Mortality Among Adults in the United States from 1999 to 2014. J Integr Complement Med 2023. View abstract.

Bourgeois P, Chales G, Dehais J, et al. Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo. Osteoarthritis Cartilage 1998;6:25-30. View abstract.

Bruyère O, Cooper C, Pelletier JP, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016;45(4 Suppl):S3-11. View abstract.

Bruyere O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Disease (ESCEO). Semin Arthritis Rheum. 2019 Dec;49(3):337-50. View abstract.

Bucsi L, Poor G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 1998;6 Suppl A:31-6. View abstract.

Burke S, Sugar J, Farber MD. Comparison of the effects of two viscoelastic agents, Healon and Viscoat on postoperative intraocular pressure after penetrating keratoplasty. Ophthalmic Surg 1990;21:821-6. View abstract.

Cao LC, Boeve ER, de Bruijn WC, et al. Glycosaminoglycans and semisynthetic sulfated polysaccharides: an overview of their potential application in treatment of patients with urolithiasis. Urology 1997;50:173-83. View abstract.

Cerda C, Bruguera M, Parés A. Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease. World J Gastroenterol 2013;19(32):5381-4. View abstract.

Nicholson, J. A., Darby, T. D., and Jarboe, C. H. Viopudial, a hypotensive and smooth muscle antispasmodic from Viburnum opulus. Proc.Soc.Exp Biol.Med. 1972;140(2):457-461. View abstract.

Ovodova, R. G., Golovchenko, V. V., Popov, S. V., Shashkov, A. S., and Ovodov, IuS. [The isolation, preliminary study of structure and physiological activity of water-soluble polysaccharides from squeezed berries of Snowball tree Viburnum opulus]. Bioorg.Khim. 2000;26(1):61-67. View abstract.

Plouvier, V. [PRESENCE OF URSOLIC ACID IN THE BLOSSOMS OF VIBURNUM OPULUS L. VAR. STERILE DC (CAPRIFOLIACEAE)]. Ann.Pharm Fr. 1964;22:313-314. View abstract.

Ryzhikov, M. A. and Ryzhikova, V. O. [Application of chemiluminescent methods for analysis of the antioxidant activity of herbal extracts]. Vopr.Pitan. 2006;75(2):22-26. View abstract.

Smetankina, P. P. [DISINFECTANT PROPERTIES OF VIBURNUM OPULUS.]. Vestn.Dermatol Venerol. 1963;37:75. View abstract.

Smirnova, A. S. and Iadrova, V. M. [Comparative study of the astringent effect of liquid extracts from Viburnum opulus L]. Farmatsiia. 1968;17(4):42-45. View abstract.

Zayachkivska, O. S., Gzhegotsky, M. R., Terletska, O. I., Lutsyk, D. A., Yaschenko, A. M., and Dzhura, O. R. Influence of Viburnum Opulus proanthocyanidins on stress-induced gastrointestinal mucosal damage. J Physiol Pharmacol 2006;57 Suppl 5:155-167. View abstract.

Gok B, Tarik Atik Y, Uysal B, Koc E, Tastemur S, Ibrahim Cimen H. Gilaburu extract (Viburnum opulus Linnaeus) is as effective as Tamsulosin in medical expulsive therapy of distal ureteral calculi. Int J Clin Pract 2021;75(12):e14950. View abstract.

Kajszczak D, Kowalska-Baron A, Podsedek A. Glycoside hydrolases and non-enzymatic glycation inhibitory potential of Viburnum opulus L. fruit-in vitro studies. Antioxidants (Basel) 2021;10(6):989. View abstract.

Kajszczak D, Kowalska-Baron A, Sosnowska D, Podsedek A. In vitro inhibitory effects of Viburnum opulus bark and flower extracts on digestion of potato starch and carbohydrate hydrolases activity. Molecules 2022;27(10):3118. View abstract.

Kajszczak D, Zaklos-Szyda M, Podsedek A. Viburnum opulus L.-A review of phytochemistry and biological effects. Nutrients. 2020;12(11):3398. View abstract.

Kizilay F, Ülker V, Çelik O, et al. The evaluation of the effectiveness of Gilaburu (Viburnum opulus L.) extract in the medical expulsive treatment of distal ureteral stones. Turk J Urol 2019. Online ahead of print. View abstract.

Nicholson JA, Darby TD, Jarboe CH. Viopudial, a hypotensive and smooth muscle antispasmodic from Viburnum opulus. Proc Soc Exp Biol Med 1972;140:457-61.

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.